Site-specific effects of dietary salt intake on guanylin and uroguanylin mRNA expression in rat intestine.
Guanylin and uroguanylin are newly discovered intestinal peptides that have been shown to affect NaCl transport in both the intestine and kidney. The present study tests the hypothesis that guanylin and uroguanylin mRNA expression in each major region of the intestine is regulated by NaCl intake. Semiquantitative multiplex RT-PCR analysis was used to determine the molecular expression of guanylin and uroguanylin in the duodenum, jejunum, ileum, and colon in rats maintained on low (LS), normal (NS), or high (HS) NaCl intake for 4 days. LS intake reduced the expression of uroguanylin, and to a lesser degree, guanylin mRNA in all intestinal segments compared to NS intake. The duodenum was the site of the greatest decrease for both. In contrast, HS intake significantly increased the expression of guanylin mRNA only in the duodenum and jejunum and had minimal effect on uroguanylin mRNA. The minimum time required for altered gene expression was determined by delivering an oral NaCl challenge directly to the gastrointestinal tract by oro-gastric administration to LS or NS animals. In LS rats, NaCl oro-gastric administration significantly increased mRNA expression of both peptides in all intestinal segments. Furthermore, the increases in guanylin and uroguanylin mRNA were detected within 4 h and plateaued by 8 h. Conversely, acute oro-gastric administration of the same NaCl solution to NS rats caused elevations of guanylin mRNA only in the duodenum and jejunum, and of uroguanylin mRNA only in the ileum and colon. In conclusion, the data demonstrate that variations in NaCl intake lead to intestinal segment-specific changes in guanylin and uroguanylin mRNA expression.
Carrithers
S L
SL
Department of Medicine, Division of Infectious Diseases, University of Kentucky and Lexington VA Medical Center, Research Services 151-CDD, 1101 VA Drive, VAMC-D309, Lexington, KY 40536, USA. Slcaru0@uky.edu
Jackson
B A
BA
Cai
W Y
WY
Greenberg
R N
RN
Ott
C E
CE
D000199:Actins / Q000235:genetics; D000818:Animals; D017931:DNA Primers; D005768:Gastrointestinal Hormones / Q000096:biosynthesis* / Q000235:genetics; D007413:Intestinal Mucosa / Q000378:metabolism*; D045265:Natriuretic Peptides; D010455:Peptides / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis* / Q000235:genetics; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D012965:Sodium Chloride / Q000008:administration & dosage; D012982:Sodium, Dietary / Q000494:pharmacology*; D013997:Time Factors
D000199:Actins; D017931:DNA Primers; D005768:Gastrointestinal Hormones; D045265:Natriuretic Peptides; D010455:Peptides; D012333:RNA, Messenger; D012982:Sodium, Dietary; C072685:guanylin; C084362:uroguanylin; D012965:Sodium Chloride